Santiago Ponce Selected Research

Santiago Ponce Research Topics

Disease

19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 02/2015
16	Neoplasms (Cancer) 05/2024 - 01/2016
10	Disease Progression 01/2022 - 08/2015
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 01/2017
4	Neutropenia 01/2023 - 08/2015
2	Malignant Mesothelioma 01/2023 - 01/2022
2	Pneumonia (Pneumonitis) 01/2022 - 01/2021
2	Sepsis (Septicemia) 01/2022 - 01/2021
2	Neoplasm Metastasis (Metastasis) 12/2020 - 01/2020
2	Melanoma (Melanoma, Malignant) 10/2020 - 03/2018
1	Bites and Stings (Sting) 02/2024
1	Prostatic Neoplasms (Prostate Cancer) 11/2023
1	Anemia 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Arthrogryposis renal dysfunction cholestasis syndrome 01/2022
1	Atrial Fibrillation 01/2022
1	Mesothelioma 01/2022
1	Liver Failure 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Adenocarcinoma of Lung 12/2021
1	Sudden Death 01/2021
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Hepatitis 01/2021
1	Multiple Organ Failure (MODS) 01/2021
1	Pancytopenia 01/2021
1	Pulmonary Embolism 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Febrile Neutropenia 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Dehydration (Water Stress) 01/2021
1	Enterocolitis 01/2021
1	Necrosis 10/2020
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2020
1	Adenocarcinoma 01/2020
1	Lung Neoplasms (Lung Cancer) 11/2019
1	Pain (Aches) 08/2019
1	Paraneoplastic Polyneuropathy 08/2019
1	Neuralgia (Stump Neuralgia) 08/2019
1	Brain Neoplasms (Brain Tumor) 06/2019
1	Inflammation (Inflammations) 01/2018
1	Infections 01/2017
1	Hyponatremia 01/2016

Drug/Important Bio-Agent (IBA)

9	PlatinumIBA 01/2023 - 08/2015
5	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2016
4	Immune Checkpoint InhibitorsIBA 05/2024 - 03/2018
4	durvalumabIBA 11/2023 - 11/2019
4	Pemetrexed (MTA)FDA Link 01/2023 - 01/2018
4	Etoposide (VP 16)FDA LinkGeneric 01/2021 - 01/2017
3	NivolumabIBA 08/2023 - 01/2020
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 01/2018 - 08/2015
2	Cell-Free Nucleic AcidsIBA 02/2024 - 11/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2017
2	Circulating Tumor DNAIBA 01/2023 - 11/2022
2	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2016
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022 - 01/2019
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2017
2	PM 01183IBA 12/2020 - 01/2020
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 01/2017
2	RamucirumabIBA 01/2018 - 01/2017
2	Gefitinib (Iressa)FDA Link 12/2017 - 08/2015
1	Abiraterone AcetateIBA 11/2023
1	enzalutamideIBA 11/2023
1	Androgen Receptors (Androgen Receptor)IBA 11/2023
1	anetumab ravtansineIBA 01/2022
1	olaparibIBA 01/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2022
1	MesothelinIBA 01/2022
1	nintedanibIBA 12/2021
1	Docetaxel (Taxotere)FDA Link 12/2021
1	tremelimumabIBA 01/2021
1	Poly I-CIBA 10/2020
1	BO-112IBA 10/2020
1	pembrolizumabIBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	secretin receptorIBA 01/2020
1	Trefoil FactorsIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Surface-Active Agents (Surfactants)IBA 01/2020
1	SerpinsIBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2018
1	ruxolitinibIBA 01/2018
1	Janus KinasesIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2017
1	lorvotuzumab mertansineIBA 01/2017
1	E-SelectinIBA 10/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2016
1	Drug CombinationsIBA 07/2016
1	necitumumabIBA 02/2016
1	Tolvaptan FDA Link 01/2016

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 08/2023 - 08/2015
10	Therapeutics 05/2024 - 07/2016
2	Aftercare (After-Treatment) 01/2020 - 10/2016
1	Castration 11/2023
1	Radiotherapy 01/2022
1	Immunotherapy 01/2020
1	Intravenous Infusions 01/2020